Antibody-mediated phagocytosis of the amyloid β-peptide in microglia is differentially modulated by C1q

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7496-7503

  Webster, S D ^a   Galvan, M D ^a   Ferran, E ^a   Garzon Rodriguez, W ^a   Glabe, C G ^a   Tenner, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT COMPONENT C1Q; FC RECEPTOR; LECTIN; LUNG SURFACTANT EXTRACT; MANNOSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

EID: 0035877075     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7496     Document Type: Article

References (49)

1. Inflammation and Alzheimer's disease
2. Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse
3. Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-β (Aβ) 1-42 peptide in a murine N9 microglial cell line
4. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor
5. Complement component C1q modulates the phagocytosis of Aβ by rat microglia
6. Structural and functional evidence for a microglial C1q receptor that enhances phagocytosis
7. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia
8. Cell surface protein identified on phagocytic cells thodulates the C1q-mediated enhancement of phagocytosis
9. Modulation of FcR function by complement: Subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages
10. Purification and radiolabeling of human C1q
11. Complement subcomponent C1q stimulates Ig production by human B lymphocytes
12. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
13. 1-40 exists as a stable dimer at low concentrations
14. Complement activation by cross-linked truncated and chimeric full-length β-amyloid
15. Disaggregation of Alzheimer β-amyloid by site-directed mAb
16. Effect of C1q on the processing of immune complexes by human neutrophils
17. Membrane receptors for soluble defense collagens
18. P is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity
19. r component of the Clq receptor
20. The IgG Fc receptor family
21. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
22. Mucosal administration of Aβ peptide decreases cerebral amyloid burden in PD-APP transgenic mice
23. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors
24. Antibody of patients with Guillan-Barre syndrome mediates complement-dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype
25. Glutamate receptor GluR3 antibodies and death of cortical cells
26. Identification of autoantibodies associated with myelin damage in multiple sclerosis
27. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: Role of cell stimulation and specific phagocytic plasma membrane receptors
28. Protein tyrosine phosphorylation induced via the IgG receptors FcγRI and FcγRII in the human monocytic cell line THP-l
29. A systematic study of neutrophil degranulation and respiratory burst in vitro by defined immune complexes
30. P, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro
31. β-peptide immunization
32. Processing and clearance of immune complexes by complement and the role of complement in immune complex diseases
33. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity
34. Regulation of mouse serum amyloid P gene expression by cytokines in vitro
35. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice
36. A microassay for the determination of hemolytic complement activity in mouse serum
37. Mouse strains with typical mammalian levels of complement activity
38. Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state
39. Multivalent binding of complement protein C1q to the amyloid β peptide (Aβ) promotes the nucleation phase of Aβ aggregation
40. Complement activation by β-amyloid in Alzheimer's disease
41. β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain
42. C1, the first component of complement: Structure-function-relationship of C1q and collectins (MBP, SP-A. SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease
43. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts
44. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis
45. x-glycosylated complement inhibitory protein
46. Gene-expression profile of the ageing brain in mice
47. Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning
48. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
49. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease